Coronary Interventions Monthly eNewletter
July 2023
As a result, the Limited Market Release (LMR) and Full Market Release (FMR) has been delayed. In the coming weeks anticipate more communications as commercialization timelines are formalized.
Thank you for being nimble around the Triumph launch. If you have any questions, please reach out to your Coronary Product Management Team.
#1 Bare Metal Stents will no longer be manufactured at Medtronic, Boston Scientific and potentially Abbott.
#2 CoPilot and Merit Valves may be on backorder again.
Please share any intel you gather regarding Bare Metal Stents or Hemostasis Valve backorders with your Coronary Product Management Team.
I want to take a moment and highlight some outstanding customer engagement by several members of the Mid-South region.
Clinician/physician engagement and education is one of our region’s top priorities in 2023 and these folks have truly taken that to heart. In just two months into Q2, with the help of the CMA team, the region has completed numerous physician/clinician engagements that range from educational events to proctorships. A few sales reps that truly standout are Matt Clayton, Nick McPherson, Kevin Daigle and Kent Copland. These individuals have brought tremendous value to industry leading physicians such as: Dr. Neupane from WakeMed in Raleigh, Dr. Borges from Atrium/Carolinas Healthcare System in Charlotte, and Dr. Leah Raj from Vanderbilt in Nashville. Topics/products educated on were GuideLiner® Coast® Catheter, Turnpike® Catheter, TrapLiner® Catheter and SuperCross™ Catheter. Matt, Nick, Kevin and Kent have gone above and beyond to help drive awareness around the incredibly important products we offer that improve patient’s lives.
~ Phillip Keever
CAUTION: Federal (USA) law restricts these devices to sale or use by or on the order of a physician.
Teleflex, the Teleflex logo, Coast, GuideLiner, SuperCross, and Triumph are trademarks or registered trademarks of Teleflex Incorporated or its affiliates in the U.S. and/or other countries. Refer to the Instructions for Use for a complete listing of the indications, contraindications, warnings, and precautions. Information in this document is not a substitute for the product Instructions for Use. Not all products may be available in all countries. Please contact your local representative.
© 2023 Teleflex Incorporated. All rights reserved. Revised 7/2023.
Would you like Teleflex Interventional to send you emails containing product news and company information? You may revoke this permission at any time by emailing InterventionalMarketingTeam@teleflex.com.
*You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.
By clicking submit below, you consent to allow Teleflex Interventional to store and process the personal information submitted above to provide you the content requested.